Alpha-1-antitrypsin is a so-called protease inhibitor, a type of enzyme inhibitor. It is produced in the liver but exerts its ...

Recent advances have marked a turning point for the treatment noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), with more therapies on the horizon to hopefully better address ...

While organoids aim to mimic human organs, the liver's repertoire of complex functions – and thus the energy it needs to operate – have made it challenging for researchers to grow organoids that ...

CSL Behring Austria today announced that the first haemophilia B patient in Austria was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Comprehensive Care Center of the ...

Belief BioMed (BBM) and Takeda China have announced the receipt of China’s NMPA approval for BBM-H901for treating haemophilia ...

Belief BioMed and Takeda China today jointly announced that BBM-H901, has been officially approved by the National Medical ...

AFLP is a rare, life-threatening condition in late pregnancy causing liver dysfunction. Early diagnosis and prompt delivery are vital for maternal recovery.

Asia's first gene-edited pig kidney transplant patient has maintained stable kidney function for more than 30 days after ...

Gallbladder disease includes inflammation, infection, stones or blockage of the gallbladder. The gallbladder is a sac located under the liver. It stores and concentrates ... Typically, a patient ...

The signs of liver failure occur in stages, starting with early symptoms such as nausea, vomiting, itchiness, and yellowing of the eyes or skin (jaundice). As it progresses, you may experience loss of ...

Despite a haemophilia market bustling with rivals, Qfitlia’s broad label and favourable dosing regimen could give it an upper hand.

Liver disease is a broad term that can describe any issue that damages the liver and affects its function. Possible causes include infections, genetic conditions, autoimmune disorders, and cancer.